Comparison of hypertension prevalence and the use of renin-angiotensin-aldosterone system blockers in hospitalized patients with COVID-19 and non-COVID-19 viral pneumonia

• Selçuk Görmez,
• Ceyda Erel Kırışoğlu,
• Mehmet Erkan Ekicibaşı,
• Aleks Değirmencioğlu,
• Ashok Paudel,
• Gökçe Akan,
• Fatmahan Atalar,
• Nevin Sarıgüzel,
• Burak Pamukçu

Affiliations

Selçuk Görmez

Department of Cardiology, Acıbadem Mehmet Ali Aydınlar University School of Medicine, İstanbul, Turkey

Ceyda Erel Kırışoğlu

Department of Chest Diseases and Tuberculosis, Faculty of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey

Mehmet Erkan Ekicibaşı

Department of Cardiology, Acibadem Altunizade Hospital, Acibadem Healthcare Group, Istanbul, Turkey

Aleks Değirmencioğlu

Department of Cardiology, Acibadem Maslak Hospital, Acibadem Healthcare Group, Istanbul, Turkey

Ashok Paudel

Department of Cardiology, Acibadem Altunizade Hospital, Acibadem Healthcare Group, Istanbul, Turkey

Gökçe Akan

Muhimbili University of Health and Allied Sciences, Department of Biochemistry, MUHAS Genetics Laboratory, Dar es Salaam, Tanzania

Fatmahan Atalar

Department of Family Health, Child Health Institute, Istanbul University, Istanbul, Turkey

Nevin Sarıgüzel

Department of Infectious Diseases, Acibadem Kadikoy & Kozyatagi Hospitals, Acibadem Healthcare Group, Istanbul, Turkey

Burak Pamukçu

Department of First and Emergency Aid, Vocational School of Health Services, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey